In a double-blind, randomised, vehicle-controlled study, patients with diabetes were randomised to receive either nepafenac eye drops or placebo 3 times daily. Medication was initiated the day prior to surgery, and continued on the day of surgery and for up to 90 days of the postoperative period. The study showed that a significantly greater proportion of patients developed macular oedema in the vehicle group (16.7%) than in the nepafenac group (3.2%).
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Formulations, doses and costs of osteoporosis supplements.
Available presentations of bronchodilators and anti-inflammatories.
Strengths and formulations of topical steroids.
Potential sensitising agents in topical steroids.